Osiris Therapeutics, Inc. (OSIR) financial statements (2022 and earlier)

Company profile

Business Address 7015 ALBERT EINSTEIN DRIVE
COLUMBIA, MD 21046
State of Incorp. MD
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2018
12/31/2017
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments24,64327,88847,89659,01034,092
Cash and cash equivalents16,3673,081 2,4161,854
Short-term investments8,27624,80747,89656,59432,238
Receivables22,46930,84123,4547,4593,063
Inventory, net of allowances, customer advances and progress billings9,61411,2789,8241,9291,278
Inventory9,61411,2789,8241,9291,278
Disposal group, including discontinued operation   91 
Prepaid expense and other current assets603
Other undisclosed current assets13,5212,9205,10215,620 
Total current assets:70,24772,92786,27684,10939,036
Noncurrent Assets
Property, plant and equipment2,8823,5872,0791,8962,111
Restricted cash and investments   243317
Other noncurrent assets3,168 95 
Deferred tax assets, net25,205    
Other undisclosed noncurrent assets 1,608 5,849 
Total noncurrent assets:31,2555,1952,1747,9882,428
TOTAL ASSETS:101,50278,12288,45092,09741,464
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:17,96414,6687,4684,8424,999
Accounts payable4,1445,269   
Accrued liabilities13,8209,399   
Other undisclosed accounts payable and accrued liabilities  7,4684,8424,999
Debt  454544
Deferred compensation liability  1,667  
Disposal group, including discontinued operation   57 
Deferred tax liabilities   5,849 
Other liabilities1,7281,934   
Other undisclosed current liabilities90018,500   
Total current liabilities:20,59235,1029,18010,7935,043
Noncurrent Liabilities
Long-term debt and lease obligation   117162
Capital lease obligations   117162
Liabilities, other than long-term debt2,3821,6263,589355369
Other liabilities2,3821,6263,589355369
Other undisclosed noncurrent liabilities   (117) 
Total noncurrent liabilities:2,3821,6263,589355531
Total liabilities:22,97436,72812,76911,1485,574
Stockholders' equity
Stockholders' equity attributable to parent78,52841,39475,68180,94935,890
Common stock3535353433
Additional paid in capital284,189283,905287,320282,702279,269
Accumulated other comprehensive loss(259)(208)(54)(33)(20)
Accumulated deficit(205,437)(242,338)(211,620)(201,754)(243,392)
Total stockholders' equity:78,52841,39475,68180,94935,890
TOTAL LIABILITIES AND EQUITY:101,50278,12288,45092,09741,464

Income statement (P&L) ($ in thousands)

12/31/2018
12/31/2017
12/31/2014
12/31/2013
12/31/2012
Revenues142,824118,51450,83524,94711,804
Revenue, net118,51450,83524,94711,804
Cost of revenue
(Cost of Goods and Services Sold)
(38,139)(32,681)(9,886)(6,718)(2,576)
Gross profit:104,68585,83340,94918,2299,228
Operating expenses(94,832)(87,822)(47,933)(20,485)(20,404)
Other undisclosed operating income (loss)   (577)25
Operating income (loss):9,853(1,989)(6,984)(2,833)(11,151)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
675(645)(1,771)41449
Income (loss) from continuing operations before income taxes:10,528(2,634)(8,755)(2,419)(11,102)
Income tax expense (benefit)26,0051,398(97)1,32637
Income (loss) from continuing operations:36,533(1,236)(8,852)(1,093)(11,065)
Income (loss) from discontinued operations368 (516)  
Income (loss) before gain (loss) on sale of properties:36,901(1,236)(9,368)(1,093)(11,065)
Other undisclosed net income 10,021   
Net income (loss) attributable to parent:36,9018,785(9,368)(1,093)(11,065)
Other undisclosed net income (loss) available to common stockholders, basic  (602)42,731 
Net income (loss) available to common stockholders, diluted:36,9018,785(9,970)41,638(11,065)

Comprehensive Income ($ in thousands)

12/31/2018
12/31/2017
12/31/2014
12/31/2013
12/31/2012
Net income (loss):36,9018,785(9,368)(1,093)(11,065)
Comprehensive income (loss):36,9018,785(9,368)(1,093)(11,065)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(51)(119)(623)42,718(40)
Comprehensive income (loss), net of tax, attributable to parent:36,8508,666(9,991)41,625(11,105)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: